SMARCB1 and malignant peripheral nerve sheath tumor: However, there have been reports of malignancy in SMARCB1-SWN and 4/75 SMARCB1-SWN patients in Manchester were reported to have developed a malignant peripheral nerve sheath tumour (MPNST) [50, 51].